Polycystic ovary syndrome was associated with a significantly higher prevalence of carotid plaque (plaque index ≥3) compared with controls (7.2% vs 0.7%, P=0.05).
Case-Control (n=267)
Does polycystic ovary syndrome increase the risk of premature carotid atherosclerosis in middle-aged women?
Women with PCOS, particularly those aged ≥45 years, exhibit increased carotid intima-media thickness and a higher prevalence of carotid plaque, indicating an elevated risk for premature atherosclerosis.
Absolute Event Rate: 7.2% vs 0.7%
p-value: p=0.05
Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder characterized by obesity, hyperandrogenism, and insulin resistance. An adverse lipid profile has also been observed in PCOS-affected women, suggesting that these individuals may be at increased risk for coronary heart disease at a young age. The objective of the present study was to evaluate subclinical atherosclerosis among women with PCOS and age-matched control subjects. A total of 125 white PCOS cases and 142 controls, aged >/=30 years were recruited. Collection of baseline sociodemographic data, reproductive hormone levels, and cardiovascular risk factors was conducted from 1992 to 1994. During follow-up (1996 to 1999), these women underwent B-mode ultrasonography of the carotid arteries for the evaluation of carotid intima-media wall thickness (IMT) and the prevalence of plaque. A significant difference was observed in the distribution of carotid plaque among PCOS cases compared with controls: 7.2% (9 of 125) of PCOS cases had a plaque index of >/=3 compared with 0.7% (1 of 142) of similarly aged controls (P=0.05). Overall and in the group aged 30 to 44 years, no difference was noted in mean carotid IMT between PCOS cases and controls. Among women aged >/=45 years, PCOS cases had significantly greater mean IMT than did control women (0.78+/-0.03 versus 0.70+/-0.01 mm, P:=0. 005). This difference remained significant after adjustment for age and BMI (P:<0.05). These results suggest that (1) lifelong exposure to an adverse cardiovascular risk profile in women with PCOS may lead to premature atherosclerosis, and (2) the PCOS-IMT association is explained in part by weight and fat distribution and associated risk factors. There may be an independent effect of PCOS unexplained by the above variables that is related to the hormonal dysregulation of this condition.
Talbott et al. (Wed,) conducted a case-control in Polycystic ovary syndrome (PCOS) (n=267). Polycystic ovary syndrome (PCOS) vs. Age-matched control subjects was evaluated on Plaque index of ≥3 (p=0.05). Polycystic ovary syndrome was associated with a significantly higher prevalence of carotid plaque (plaque index ≥3) compared with controls (7.2% vs 0.7%, P=0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: